These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fluoxetine (Sarafem) for premenstrual dysphoric disorder. Med Lett Drugs Ther; 2001 Jan; 43(1096):5-6. PubMed ID: 11177220 [No Abstract] [Full Text] [Related]
23. Selective serotonin reuptake inhibitors for premenstrual syndrome. Brown J; O' Brien PM; Marjoribanks J; Wyatt K Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564 [TBL] [Abstract][Full Text] [Related]
24. SSRI use during pregnancy. Tran H; Robb AS Semin Perinatol; 2015 Nov; 39(7):545-7. PubMed ID: 26428019 [TBL] [Abstract][Full Text] [Related]
25. Use of SSRIs in pregnancy: neonatal implications. Courtney K Nurs Womens Health; 2009 Jun; 13(3):234-8. PubMed ID: 19523137 [No Abstract] [Full Text] [Related]
26. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications. Cantor Sackett J; Weller RA; Weller EB Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium. Deligiannidis KM J Clin Psychiatry; 2010 May; 71(5):649-50. PubMed ID: 20492855 [No Abstract] [Full Text] [Related]
28. Antidepressants in the postpartum period: additional considerations. Burbeck R; Pilling S; Tomson D; McDonald L Am J Psychiatry; 2008 Feb; 165(2):262-3; author reply 263. PubMed ID: 18245193 [No Abstract] [Full Text] [Related]
29. SSRIs for premenstrual dysphoric disorder. Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224 [TBL] [Abstract][Full Text] [Related]
31. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines]. Mejías C; Rodríguez-Pinilla E; Fernández Martín P; Martínez-Frías ML Med Clin (Barc); 2007 Apr; 128(15):584-9. PubMed ID: 17462198 [TBL] [Abstract][Full Text] [Related]
32. Relapse of depression during pregnancy and postpartum periods in Japanese women associated with self-interruption of their medications: Selective serotonin reuptake inhibitors. Suzuki S Asian J Psychiatr; 2015 Dec; 18():99. PubMed ID: 26603370 [No Abstract] [Full Text] [Related]
33. [SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio]. Weisskopf E; Fumeaux CJ; Bickle Graz M; Harari MM; Epiney M; Tolsa CB; Rouiller S; Tolsa JF; Eap CB; Vial Y; Csajka C; Panchaud A Rev Med Suisse; 2016 Mar; 12(510):561-6. PubMed ID: 27149719 [TBL] [Abstract][Full Text] [Related]
35. Selective serotonin reuptake inhibitors for premenstrual syndrome. Marjoribanks J; Brown J; O'Brien PM; Wyatt K Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611 [TBL] [Abstract][Full Text] [Related]
36. Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis. McDonagh MS; Matthews A; Phillipi C; Romm J; Peterson K; Thakurta S; Guise JM Obstet Gynecol; 2014 Sep; 124(3):526-534. PubMed ID: 25004304 [TBL] [Abstract][Full Text] [Related]
37. Warning of risk to foetus for mothers using SSRIs. Kouros N Monash Bioeth Rev; 2013 Sep; 31(2):22-3. PubMed ID: 24844071 [No Abstract] [Full Text] [Related]
38. Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women. Huttner RP; Shepherd JE Med Clin North Am; 2003 Sep; 87(5):1065-76. PubMed ID: 14621331 [TBL] [Abstract][Full Text] [Related]
39. Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression. Mace S; Taylor D Expert Opin Pharmacother; 2000 Jul; 1(5):917-33. PubMed ID: 11249500 [TBL] [Abstract][Full Text] [Related]
40. Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy. Mills JL N Engl J Med; 2006 Feb; 354(6):636-8. PubMed ID: 16467553 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]